Products - Ear, nose and throat conditions | Topic | NICE

Showing 6 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

12 SQ-HDM SLIT for treating allergic rhinitis and allergic asthma caused by house dust mites (review of TA834) [ID6280]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
12 February 2025
Betula verrucosa (Itulazax 12 SQ-Bet) for treating moderate to severe allergic rhinitis, conjunctivitis, or both, caused by tree pollen ID6462
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
11 September 2025
Corticosteroid-releasing bioabsorbable stent or spacer insertion during endoscopic sinus surgery to treat chronic rhinosinusitis
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
5 February 2025
Dupilumab for treating severe chronic rhinosinusitis with nasal polyposis (Review of TA648) [ID6480]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
11 September 2025
Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6440]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
12 November 2025
Topical rapamycin for treating facial angiofibromas associated with tuberous sclerosis complex in people 6 years and over [ID6391]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC